Marion Biotech had come under the scanner in December last year for its cough syrup Dok-1 that is suspected to have led to the death of 18 children who consumed it in Uzbekistan after which the CDSCO launched a probe into the matter.The production licence of the firm was suspended in January after inspections at its site by the central and the state drug authorities in the wake of the controversy.